期刊文献+

2型糖尿病合并脑梗塞患者血浆脂联素的变化研究

Changes of plasma adiponection in patients with type2 diabetes mellitus associated with cerebral infarction
下载PDF
导出
摘要 目的探讨2型糖尿病患者及其合并脑梗塞患者中血浆脂联素水平的变化。方法选取2型糖尿病患者83例(A组)、合并脑梗塞患者20例(B组)、健康对照者35例(C组)作为研究对象。测定受试者血浆脂联素水平、血压、体重等,比较脂联素水平的改变,以及与其它因素的相关性。结果A组血浆脂联素水平明显低于C组(P<0.01),B组血浆脂联素又明显低于A组(P<0.01)。在糖尿病患者中,血浆脂联素与收缩压(SBP)呈负相关(r=-0.309,P<0.01)。结论对2型糖尿病患者及2型糖尿病合并脑梗塞者检测血浆脂联素水平具有临床诊断价值。 Objective To assay the changes of the plasma adiponection in patients with type2 diabetes mellitus and with type2 diabetes mellitus associate d with cerebral infarction. Methods 83 patients with type2 diabetes m ellitus (group A), 20 patients with type2 diabetes mellitus associated with cere bral infarction (group B) and 35 healthy subjects (group C) were chosen in the s tudy. In all of the selected individuals, the levels of plasma adiponection, blo od pressure and weight had been detected. Comparison of adiponction levels and its correlation with other factors had been done. Results Levels of plasma adiponection in group A was significantly lower than that in gr oup C (P<0.01), and plasma adiponection in group B was significantly lower t han that in group A (P<0.01). In patients with diabetes mellitus, plasma adi ponection had negative correlation with SBP (R=-0.309, P<0.01). Conclusion The determination o f plasma adiponection is valuable in clinical diagnosis of type2 diabetes mellit us and type2 diabetes mellitus associated with cerebral infarction.
出处 《右江民族医学院学报》 2005年第3期286-288,共3页 Journal of Youjiang Medical University for Nationalities
基金 广西卫生厅科研项目(合同号:Z2004095)
关键词 糖尿病 脑梗塞 脂联素 diabetes mellitus brain infarction adiponect ion factor analysis, statistical
  • 相关文献

参考文献9

二级参考文献82

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2[1]Yoda-Murakami M, Taniguchi M, Takahashi K, et al. Change in expression of GBP28/adiponectin in carbon tetrachloride administrated mouse liver. Biochem Biophys Res Commun, 2001, 285:372-377.
  • 3[2]Nakano Y, Tobe T, Choi-Miura NH, et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from humpa plasma. J Biochem (Tokyo), 1996, 120: 803-812.
  • 4[3]Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 2001,86: 1930-1935.
  • 5[4]Hotta K, Funahashi T, Bodkin NL, et al. Circulating oncentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes, 2001, 50: 1126-1133.
  • 6[5]Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord, 2000, 24: 861-868.
  • 7[6]Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population.Lancet, 2002, 360:57-58
  • 8[7]Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 2001, 7: 941-946.
  • 9[8]Statnick MA, Beavers LS, Conner LJ, et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res, 2000, 1: 81-88.
  • 10[9]Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Diabetes Care, 1999, 22(Suppl 3): C25-30

共引文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部